Back to Search
HARPREET BHUTANI, MD
MD
Nephrology Physician
NPI: 1154553089IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
D0077449(MD)0101257036(VA)
Education
OTHER
Class of 2006
Research & Publications (14)
Screening of bulk drug samples and anti-tuberculosis products for the presence of therapeutically less active diasteriomeric (R,S) form of ethambutol dihydrochloride.
PMID 19295106·Indian J Tuberc·2008
8-other
Provider response to insulin-induced hypoglycemia in hospitalized patients.
PMID 17705211·J Hosp Med·2007
8-other
Hyperglycemia and length of stay in patients hospitalized for bone marrow transplantation.
PMID 17259474·Diabetes Care·2007
8-other
LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
PMID 17118610·J Pharm Biomed Anal·2007
8-other
ICH guidance in practice: validated stability-indicating HPLC method for simultaneous determination of ampicillin and cloxacillin in combination drug products.
PMID 16959462·J Pharm Biomed Anal·2007
4-observational
Study of the interaction between rifapentine and isoniazid under acid conditions.
PMID 16621412·J Pharm Biomed Anal·2006
8-other
Refocus on the stability and quality of anti-tuberculosis formulations.
PMID 16964804·Int J Tuberc Lung Dis·2006
8-other
Drug-drug interaction studies on first-line anti-tuberculosis drugs.
PMID 16370181·Pharm Dev Technol·2005
8-other
Behavior of moisture gain and equilibrium moisture contents (EMC) of various drug substances and correlation with compendial information on hygroscopicity and loss on drying.
PMID 16370178·Pharm Dev Technol·2005
8-other
Mechanistic explanation to the catalysis by pyrazinamide and ethambutol of reaction between rifampicin and isoniazid in anti-TB FDCs.
PMID 15978767·J Pharm Biomed Anal·2005
8-other
Novel anti-tuberculosis FDC formulations without reduced bioavailability of rifampicin: from concept to market.
PMID 15971403·Int J Tuberc Lung Dis·2005
8-other
The physical and chemical stability of anti-tuberculosis fixed-dose combination products under accelerated climatic conditions.
PMID 15455591·Int J Tuberc Lung Dis·2004
8-other
An explanation for the physical instability of a marketed fixed dose combination (FDC) formulation containing isoniazid and ethambutol and proposed solutions.
PMID 15285340·Drug Dev Ind Pharm·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7610 CARROLL AVE STE 270
TAKOMA PARK, MD 20912 - Phone
- (301) 270-4360
Quick Facts
- NPI
- 1154553089
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 20
- Publications
- 14
Are you this provider?
Claim Your Profile